Cholestatic jaundice associated with lovastatin (Mevacor) therapy.
作者信息
McQueen M J
机构信息
McMaster University, Hamilton, Ont.
出版信息
CMAJ. 1990 Apr 15;142(8):841-2.
Abstract
摘要
相似文献
1
Cholestatic jaundice associated with lovastatin (Mevacor) therapy.与洛伐他汀（美降脂）治疗相关的胆汁淤积性黄疸。
CMAJ. 1990 Apr 15;142(8):841-2.
2
Lovastatin: cholesterol-lowering agent.洛伐他汀：降胆固醇药。
Am Fam Physician. 1987 Dec;36(6):189-92.
3
4
Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.环孢素A治疗的高脂血症肾移植受者服用低剂量洛伐他汀。
Transplant Proc. 1992 Dec;24(6):2745-7.
5
[Cholestatic jaundice during lovastatin medication].[洛伐他汀用药期间的胆汁淤积性黄疸]
Dtsch Med Wochenschr. 1991 May 10;116(19):739-40. doi: 10.1055/s-2008-1063673.
6
Cholestatic jaundice associated with lovastatin (mevacor) therapy.与洛伐他汀（美降脂）治疗相关的胆汁淤积性黄疸。
CMAJ. 1990 Jul 1;143(1):13-4.
7
Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
Int J Clin Pharmacol Res. 1994;14(5-6):177-83.
8
Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits.洛伐他汀和苯扎贝特对环孢素诱导的兔高脂血症的影响。
Transplant Proc. 1995 Apr;27(2):1857-61.
9
Management of primary mixed hyperlipidemia with lovastatin.
Arch Intern Med. 1990 Jun;150(6):1313-9.
引用本文的文献
1
Rosuvastatin-Induced Dizziness and Pruritus: A Case Report and Summary of Statin-Associated Dizziness and Pruritus.瑞舒伐他汀引起的头晕和瘙痒：一例病例报告及他汀类药物相关头晕和瘙痒的综述
Cureus. 2022 Sep 10;14(9):e29014. doi: 10.7759/cureus.29014. eCollection 2022 Sep.
2
Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.他汀类药物所致高转氨酶血症的风险：一项随机对照试验的系统评价和荟萃分析
Mayo Clin Proc Innov Qual Outcomes. 2019 May 5;3(2):131-140. doi: 10.1016/j.mayocpiqo.2019.01.003. eCollection 2019 Jun.
3
The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.HMG-CoA还原酶抑制剂对辅酶Q10的影响：可能的生化/临床意义。
Drug Saf. 2005;28(8):659-76. doi: 10.2165/00002018-200528080-00002.
4
A general assessment of the safety of HMG CoA reductase inhibitors (statins).HMG CoA还原酶抑制剂（他汀类药物）安全性的综合评估。
Curr Atheroscler Rep. 2002 Jan;4(1):34-41. doi: 10.1007/s11883-002-0060-0.
5
How well tolerated are lipid-lowering drugs?降脂药物的耐受性如何？
Drugs Aging. 2001;18(9):665-83. doi: 10.2165/00002512-200118090-00003.
6
Lovastatin and cholestasis.洛伐他汀与胆汁淤积
CMAJ. 1993 Feb 1;148(3):374.
7
Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin.由HMG-CoA还原酶抑制剂洛伐他汀引起的急性肝炎。
Dig Dis Sci. 1994 Sep;39(9):2032-3. doi: 10.1007/BF02088142.
8
Cholestatic jaundice associated with lovastatin (mevacor) therapy.与洛伐他汀（美降脂）治疗相关的胆汁淤积性黄疸。
CMAJ. 1990 Jul 1;143(1):13-4.
Zotero 插件